July 6, 2015

The Food and Drug Administration recently approved Orkambi a new cystic fibrosis treatment that received designation from the FDA as a breakthrough therapy and as an orphan drug. 

May 28, 2015

Camber Pharmaceuticals on Thursday announced that it had launched antipsychotic drug aripiprazole — a generic version of Abilify — in 2-, 5-, 10-, 15-, 20- and 30-mg dosage strength tablets. 

April 29, 2015

The Food and Drug Administration announced approval for the first generic versions of aripiprazole tablets.

December 30, 2014

Vertex Pharmaceuticals has announced that the Food and Drug Administration approved a supplemental new drug application for the use of Kalydeco (ivacaftor) in people with cystic fibrosis ages 6 years and older who have the R117H mutation in the cystic fibrosis transmembrane conductance regulator gene.

March 1, 2013

The Food and Drug Administration has approved a once-monthly treatment for schizophrenia.

January 15, 2013

Drug maker Otsuka Pharmaceuticals can keep generic versions of its schizophrenia drug off the market, according to published reports.